Phase II Pharmacodynamic Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease

NCT01053936 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

129

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Insufficiency, Chronic
Diabetes Mellitus, Type 2

Interventions

DRUG: Bardoxolone methyl (amorphous dispersion)

Sponsor

Biogen